ABBOTT LABORATORIES, SA

ABBOTT LABORATORIES, SA specializes in the manufacturing of in-vitro diagnostic substances, delivering precision laboratory reagents and control materials critical for clinical testing and biomedical analysis. Their technical expertise lies in the development and production of calibrated diagnostic controls, assay standards, and quality assurance materials used in immunoassays, molecular diagnostics, and clinical chemistry platforms. The company’s capabilities center on high-purity substance synthesis, lot-to-lot consistency validation, and regulatory-compliant manufacturing processes aligned with ISO 13485 and CLIA guidelines, ensuring reliability in diagnostic instrumentation across laboratory environments. Their focus on control substances suggests deep specialization in analytical traceability, matrix stabilization, and reference material certification—key differentiators for laboratories requiring reproducible results in high-volume diagnostic workflows. The contractor has delivered products to the Department of Defense, indicating a role in supporting military medical readiness through diagnostic quality control. Their work likely supplies field hospitals, military labs, and deployed medical units with validated controls for infectious disease screening, blood banking, and point-of-care testing systems. This relationship reflects a mission-critical partnership in sustaining diagnostic accuracy under austere conditions. The primary NAICS code 325413 reflects a narrow but vital market niche: the production of laboratory-grade diagnostic substances used to calibrate, validate, and monitor the performance of clinical analyzers. This vertical specialization positions the contractor as a supplier of essential reference materials rather than end-user diagnostic devices, serving a foundational role in the diagnostic supply chain. Abbott Laboratories, SA is structured as an X6 entity, indicating a small business classification under federal contracting rules. Based on available data, the company operates from Madrid with no publicly listed government certifications. Its market presence is defined by specialized, high-precision manufacturing rather than broad-scale distribution, serving niche but essential roles in defense and clinical diagnostics infrastructure.